Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
19.3M
-
Shares change
-
+400K
-
Total reported value, excl. options
-
$1.07B
-
Value change
-
+$20.4M
-
Put/Call ratio
-
3.18
-
Number of buys
-
93
-
Number of sells
-
-91
-
Price
-
$55.28
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2024
240 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q4 2024.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.3M shares
of 22.3M outstanding shares and own 86.53% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.74M shares), VANGUARD GROUP INC (1.31M shares), MILLENNIUM MANAGEMENT LLC (1M shares), STATE STREET CORP (737K shares), GOLDMAN SACHS GROUP INC (700K shares), DIMENSIONAL FUND ADVISORS LP (686K shares), Deep Track Capital, LP (649K shares), Global Alpha Capital Management Ltd. (625K shares), UBS Group AG (595K shares), and CITADEL ADVISORS LLC (592K shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.